PREVALENCE OF CO-MORBIDITIES IN OBESE PATIENTS BEFORE AND AFTER BARIATRIC SURGERY IN MADINAH REGION
Abstract
Background: Obesity is a global public health concern associated with numerous comorbidities and reduced quality of life. Bariatric surgery has emerged as an effective intervention for weight loss. However, there is limited research on the prevalence of comorbidities before and after bariatric surgery in Madinah Region, Saudi Arabia.
Objective: This study aimed to determine the prevalence of co-morbidities in obese patients before and after bariatric surgery in Madinah region.
Methods: A retrospective analysis was conducted on medical records of obese patients who underwent bariatric surgery in Madinah region. Data were collected on co-morbidities, including diabetes mellitus (DM), hypertension (HTN), hypothyroidism, asthma, polycystic ovary syndrome (PCOS), cardiovascular diseases, osteoarthritis, gastrointestinal diseases, sleep apnea, hypercholesterolemia, and hyperprolactinemia. Prevalence rates of these co-morbidities were calculated for the periods before and after surgery.
Results: A total of 170 patients were included in the study. Statistically significant differences were observed in the prevalence of DM, HTN, asthma, hypothyroidism, and PCOS when comparing pre- and post-operative data. The impact of bariatric surgery on DM and HTN according to levels of obesity showed that among cases with a BMI of 40 kg/m2 or higher, there was a higher rate of clinical improvement and a greater likelihood of reducing medication dosages compared to cases with BMI < 40 kg/m2.
Conclusion: The findings suggest that bariatric surgery may reduce the prevalence of co-morbidities in this population. These results show the benefits of bariatric surgery and emphasize the importance of considering comorbidities in the management of obesity.